Katie White

Associate Professor

University of Minnesota
Country flagUnited States

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Katie White is an Associate Professor at the University of Minnesota, USA. Her research focuses on medication management during transitions of care, cross-sector partnerships for population health, and health disparities among diverse populations. Recent articles highlight her work on integrating clinical pharmacists, stakeholder engagement in healthcare improvements, and the implementation of standardized reporting practices in clinical settings.

Articles (5)

Year:

2025

Background Comprehensive medication management (CMM) is a service provided by clinical pharmacists. CMM aims to optimize pharmacotherapy outcomes by ensuring patients' medications are indicated, effective, safe, and patients are able to adhere to the prescribed medication regimen and take the medications as intended. The goal of CMM is to optimize patients' medications to ensure they are meeting their medication and health‐related goals. Objective The objective of this project is to evaluate facilitators and barriers to integrating CMM during transitions of care (ToC) at Federally Qualified Health Centers (FQHCs). Design Semistructured qualitative interviews were conducted with 22 key informants identified through purposive sampling at three FQHCs. Interviews were coded and analyzed deductively using a modified Consolidated Framework for Implementation Research (CFIR) adapted for ToC. Key Results Thirty‐nine codes were identified across all CFIR constructs, including the addition of a new construct, “Patient characteristics.” Major facilitators included the perceived advantage and feasibility of the intervention, standardization of ToC processes, and organizational buy‐in. Major barriers included health information technology system limitations, communication barriers with discharge facilities, technical and staffing challenges in applying criteria to identify patients for CMM, and low patient throughput. Conclusions Identifying early‐stage barriers and facilitators are key to maximize facilitators and address barriers to support successful implementation. The findings of this work are being used to guide project adaptations to better integrate CMM into the ToC processes.

Year:

2024

Year:

2022

Year:

2021

Year:

2020

Collaborators (3)

Joel F. Farley

-

UNITED STATES
View details

Deborah L. Pestka

-

UNITED STATES
View details

James Begun

Professor

Regents of the University of Minnesota

UNITED STATES
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.